Noven Pharms Inc Drug Patent Portfolio

Noven Pharms Inc owns 3 orange book drugs protected by 13 US patents Given below is the list of Noven Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11559501 Transdermal amphetamine compositions with low levels of carbamate 06 Jan, 2042
Active
US9456993 Compositions and methods for transdermal delivery of amphetamine 24 Oct, 2033
Active
US9474722 Compositions and methods for transdermal delivery of amphetamine 24 Oct, 2033
Active
US8632802 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
Active
US9034370 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
Active
US9668981 Device for transdermal administration of drugs including acrylic based polymers 07 Oct, 2025
Active
US8591941 Transdermal drug delivery device including an occlusive backing 07 Oct, 2025
Active
US6210705 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate 30 Sep, 2018 Expired
US6348211 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate 30 Sep, 2018 Expired
US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Aug, 2014 Expired
US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration 07 Jan, 2014 Expired
US5474783 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012 Expired
US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Noven Pharms Inc.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 24 Jan, 2023 US11559501
Recordation of Patent Grant Mailed 24 Jan, 2023 US11559501
Email Notification 05 Jan, 2023 US11559501
Issue Notification Mailed 04 Jan, 2023 US11559501
Dispatch to FDC 23 Dec, 2022 US11559501
Application Is Considered Ready for Issue 23 Dec, 2022 US11559501
Issue Fee Payment Verified 16 Dec, 2022 US11559501
Issue Fee Payment Received 16 Dec, 2022 US11559501
Response to Reasons for Allowance 16 Dec, 2022 US11559501
Electronic Review 22 Nov, 2022 US11559501
Email Notification 22 Nov, 2022 US11559501
Mail Notice of Allowance 22 Nov, 2022 US11559501
Notice of Allowance Data Verification Completed 17 Nov, 2022 US11559501
Interview Summary - Examiner Initiated - Telephonic 07 Nov, 2022 US11559501
Information Disclosure Statement considered 07 Nov, 2022 US11559501


Noven Pharms Inc's Family Patents

Noven Pharms Inc drugs have patent protection in a total of 11 countries. It has a significant patent presence in the US with 55.8% of its patents being US patents. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Noven Pharms Inc Drug List

Given below is the complete list of Noven Pharms Inc's drugs and the patents protecting them.


1. Combipatch

Combipatch is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Aug, 2014
(10 years ago)
Expired
US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration 07 Jan, 2014
(10 years ago)
Expired
US5474783 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012
(11 years ago)
Expired
US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combipatch's drug page


2. Daytrana

Daytrana is protected by 6 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8632802 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
(11 months from now)
Active
US9034370 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
(11 months from now)
Active
US9668981 Device for transdermal administration of drugs including acrylic based polymers 07 Oct, 2025
(11 months from now)
Active
US6210705 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate 30 Sep, 2018
(6 years ago)
Expired
US6348211 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate 30 Sep, 2018
(6 years ago)
Expired
US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Daytrana's drug page


3. Xelstrym

Xelstrym is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11559501 Transdermal amphetamine compositions with low levels of carbamate 06 Jan, 2042
(17 years from now)
Active
US9456993 Compositions and methods for transdermal delivery of amphetamine 24 Oct, 2033
(9 years from now)
Active
US9474722 Compositions and methods for transdermal delivery of amphetamine 24 Oct, 2033
(9 years from now)
Active
US8591941 Transdermal drug delivery device including an occlusive backing 07 Oct, 2025
(11 months from now)
Active
US8632802 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
(11 months from now)
Active
US9034370 Device for transdermal administration of drugs including acrylic polymers 07 Oct, 2025
(11 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xelstrym's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List